VR VRTX $549.04 ▲ +3.44% Should I Buy Vertex Pharmaceuticals (VRTX)? Finance YouTuber Analysis
VERDICT: STRONG BUY 0/100
Get weekly updates on this stock
“This creator notes Vertex Pharmaceuticals' joint FDA approval with CRISPR Therapeutics for Casgevy, a gene-editing therapy for sickle cell disease.…”
Financials
Reported figures · last 5 yearsCall record — VRTX
5 CALLS · 3 BUY / 0 SELL / 0 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Vertex Pharmaceuticals?
3 finance YouTubers analysed Vertex Pharmaceuticals with qualified reasoning — consensus: Buy, average analysis quality 72/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Vertex Pharmaceuticals?
Among the channels covering Vertex Pharmaceuticals, 3 are buying and 0 are selling or avoiding — overall Buy.
What price target do YouTubers give Vertex Pharmaceuticals?
The price targets mentioned for Vertex Pharmaceuticals range 258. Targets are the YouTubers' own; not a guarantee.
How do you decide what to include for Vertex Pharmaceuticals?
Only qualified analyses count: a clear buy/sell stance on Vertex Pharmaceuticals with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.